Could a New Cannabis-Based Medication Change Chronic Pain Treatment? What West Virginia Patients Should Know
Updated: 1d
Don’t miss important updates about West Virginia’s marijuana program. Subscribe to our newsletter and get the latest straight to your email!
For West Virginians struggling with chronic pain, finding an effective treatment can be a long and frustrating process. Some patients experience limited relief from conventional medications, while others face unwanted side effects that make long-term pain management more difficult.
Now, a new U.S. clinical trial is examining whether a cannabis-derived medication could offer another treatment option.
VER-01 combines several cannabinoids, including THC, CBD, and CBG, in carefully measured amounts to ensure each dose has a consistent composition. Following encouraging results in Europe, researchers are beginning additional testing in the United States to evaluate its effects on chronic lower back pain.
With severe chronic or intractable pain recognized as a qualifying condition under West Virginia's medical marijuana program, this research is particularly relevant to patients interested in learning more about marijuana-based medicine.
Why Scientists Are Investigating Marijuana as an Alternative Pain Treatment
Chronic pain is one of the most challenging conditions to manage because symptoms, underlying causes, and responses to treatment vary significantly between individuals.
Traditional pain management may involve physical therapy, anti-inflammatory medications, injections, or prescription pain relievers. Opioid medications are sometimes prescribed for certain types of pain, but their use can involve risks such as dependence, constipation, sedation, and overdose.
Researchers have therefore been exploring whether cannabinoid-based medications might provide additional treatment options.
Cannabinoids interact with the body's endocannabinoid system, a network involved in regulating functions such as pain perception, sleep, and other physiological processes.
Although marijuana has been used for medical purposes for many years, researchers are still working to establish which cannabinoid formulations may be most effective for particular conditions.
VER-01 is one of the medications currently being investigated.
Understanding VER-01: A Standardized Cannabis Medication
VER-01 was developed by Vertanical, a pharmaceutical company based in Germany.
Unlike conventional medical marijuana products, VER-01 is manufactured with a controlled cannabinoid composition intended to provide consistent dosing.
Its formulation contains three notable marijuana compounds:
THC: Tetrahydrocannabinol is the primary intoxicating component of marijuana. Researchers are studying its effects on pain signaling and other functions of the nervous system.
CBD: Cannabidiol does not produce the intoxicating effects typically associated with THC. It continues to be investigated for several potential medical applications.
CBG: Cannabigerol is a less extensively researched cannabinoid that scientists are examining for possible therapeutic properties.
The combination of these cannabinoids is being evaluated as a specific medication, rather than as a substitute for every type of marijuana product.
U.S. Researchers Begin Testing VER-01 for Lower Back Pain
In October 2026, NORML reported that investigators in western New York were beginning a clinical trial involving VER-01. The research is being conducted with investigators affiliated with Upstate Clinical Research Associates in Williamsville, near Buffalo.
Participants include individuals experiencing chronic lower back pain who have not obtained adequate relief from opioid-based treatments.
The study uses a placebo-controlled design to help researchers distinguish the medication's effects from improvements that may occur without active treatment.
Investigators will assess whether VER-01 can meaningfully reduce pain, improve sleep and daily functioning, and demonstrate an acceptable safety profile.
The results may help guide future decisions about the medication's development and potential approval.
What Have Clinical Trials Found So Far?
Before research expanded to the United States, VER-01 underwent clinical testing in Europe.
One important Phase 3 trial published in Nature Medicine involved 820 adults with chronic lower back pain.
Patients receiving VER-01 reported an average reduction of 1.9 points on an 11-point pain scale, while participants receiving a placebo experienced an average reduction of 1.4 points. Researchers also observed improvements in certain measures of sleep, mobility, and quality of life.
A separate Phase 3 study published in Pain and Therapy examined 384 adults and compared VER-01 with opioid-based medications over six months. The VER-01 group experienced somewhat greater average improvements in pain and sleep, along with fewer reports of constipation.
These results suggest that the medication warrants further investigation. However, they do not establish that all cannabis products are effective for chronic pain or that cannabinoids are appropriate replacements for prescribed opioid medications.
Patients should never discontinue or change prescribed medications without consulting their healthcare professional.
Why This Research Matters in West Virginia
West Virginia has experienced substantial challenges related to opioid misuse and overdose, making research into additional pain management options an important public health topic.
However, investigating alternatives to opioids does not mean that marijuana is a proven solution to opioid dependence or overdose. Those questions require separate scientific evaluation.
For West Virginia patients, the VER-01 research is particularly interesting because the state's medical marijuana program recognizes severe chronic or intractable pain, including pain of neuropathic origin, among its qualifying conditions.
Eligible patients who receive the required marijuana doctor certification and state approval can obtain medical marijuana from licensed West Virginia dispensaries.
While clinical trials like the VER-01 study may contribute to the broader understanding of cannabinoid-based treatments, they do not change the state's existing eligibility requirements.
How Is VER-01 Different From Medical Marijuana Sold in West Virginia?
Patients should understand that the cannabis-based medication being studied in New York is not the same as the products currently available through West Virginia's medical marijuana program.
VER-01 is a standardized pharmaceutical extract designed for controlled clinical testing.
West Virginia dispensaries offer state-authorized medical marijuana products in approved forms, including oils, tinctures, pills, topical preparations, and certain products intended for vaporization.
Different products can contain different amounts of THC, CBD, and other cannabinoids. Their effects may also vary depending on the formulation, method of administration, and individual patient characteristics.
For these reasons, results from clinical trials involving VER-01 should not be interpreted as evidence that every medical marijuana product will provide the same benefits.
Patients should work with qualified healthcare professionals to understand the potential risks, limitations, and considerations associated with medical marijuana.
Has the FDA Approved VER-01?
VER-01 has not received FDA approval for general use.
In 2026, the U.S. Food and Drug Administration granted the medication Breakthrough Therapy Designation following promising clinical findings.
This designation is intended to facilitate the development and review of certain investigational medications that may offer substantial improvements over existing treatments. However, it does not establish that a medication is safe or effective, and it does not authorize general prescribing or commercial distribution.
Additional research and regulatory review are necessary before VER-01 could become an approved prescription treatment.
The medication is not currently available for purchase at West Virginia medical marijuana dispensaries.
Can Chronic Pain Patients Qualify for Medical Marijuana in West Virginia?
Yes. Severe chronic or intractable pain is one of the qualifying medical conditions under West Virginia's medical marijuana program. If you're experiencing persistent pain, you may be eligible to receive a medical marijuana card.
At West Virginia Marijuana Card, we make the process simple with convenient online evaluations and support throughout registration. To get started, patients must:
Have a qualifying medical condition recognized under West Virginia law.
Complete an online evaluation with a qualified marijuana doctor who can determine whether they meet the state's medical requirements.
Receive a medical certification if approved.
Complete the state registration process through the West Virginia Office of Medical Cannabis.
Receive state approval before purchasing medical marijuana from a licensed dispensary.
A diagnosis of severe chronic or intractable pain does not automatically guarantee approval. A marijuana doctor must evaluate your medical history and determine whether you meet the program's requirements.
Ready to get started? Schedule an online evaluation with West Virginia Marijuana Card and let our team help guide you through the process.
What Comes Next for Marijuana-Based Pain Research?
The VER-01 clinical trial is part of a larger effort to better understand the possible medical applications of cannabinoids.
Researchers are examining whether specific formulations can provide measurable benefits while maintaining acceptable safety standards. For West Virginia patients, these developments may help inform future conversations about pain management and the potential role of cannabis-derived medications.
Nevertheless, more evidence is needed before VER-01 can become an approved treatment.
In the meantime, patients interested in medical marijuana should understand their options under West Virginia law and seek individualized medical guidance.
Get Your Medical Marijuana Card Today!
Medical marijuana is legal in the state of West Virginia, and you can apply for your very own medical card today! You need your medical card to visit any dispensary in the state.
If you think you may benefit from medical marijuana, there is a good chance you will qualify for a card. It is now easier than ever to get your card with telemedicine, right from the comfort of your own home!
If approved, your certification is submitted to the West Virginia Office of Medical Cannabis. After completing your state application and receiving approval, you'll get a digital medical cannabis card, allowing you to purchase products at licensed dispensaries with a valid photo ID.
Being a West Virginia medical marijuana patient allows you the freedom to establish your personalized treatment plan. We’re dedicated to helping patients every step of the way!
Feel free to give us a call at 877-303-8424, and we can answer your questions about getting a medical marijuana card in West Virginia.
Doctors Who Care.
Relief You Can Trust.
West Virginia Marijuana Card’s mission is to help everyone achieve wellness safely and conveniently through increased access to medical marijuana. Our focus on education, inclusion, and acceptance will reduce the stigma for our patients by providing equal access to timely information and compassionate care.
If you have any questions, call us at 877-303-8424, or simply book a medical marijuana evaluation to start getting relief you can trust today!
Check out West Virginia Marijuana Card’s Blog to keep up to date on the latest medical marijuana news, tips, and information.
For more blogs like this, plus patient resources and state updates, sign up for our newsletter!
Comments